Navigation Links
News briefs from the March issue of Chest
Date:3/4/2010

PREGNANT SMOKERS WITH ASTHMA HAVE INCREASED HEALTH RISKS

Pregnant women with asthma who smoke have an increased risk for asthma symptoms and fetal growth abnormalities. Researchers from the Medical University of South Carolina observed 2,210 pregnant women with asthma to determine the effect of active and passive household smoking on asthma severity and obstetric/neonatal outcomes. Of the women, 418 (18 percent) reported active smoking; among nonsmokers, 790 (36 percent) reported passive household smoke exposure. Results showed that active smoking was associated with an increase in total symptomatic days and nights of sleep disturbance. Among newborns of active smokers, there was a greater risk of small for gestational age and a lower mean birth weight. There were no differences in symptom exacerbation or outcome between nonsmokers with and without passive household smoke exposure. This study is published in the March issue of CHEST, the peer-reviewed journal of the American College of Chest Physicians: CHEST 2010; 137(3):601�.

AIRWAY OBSTRUCTION DOMINATES HEALTH ISSUES IN FDNY WTC WORKERS

New evidence shows that airway obstruction may be the cause of reduced lung function in World Trade Center (WTC) rescue workers from the New York City Fire Department (FDNY). Researchers from FDNY, New York University, and Albert Einstein College of Medicine, analyzed pulmonary function test results in 1,750 participants from the FDNY-WTC Monitoring Program. Of the participants, 59 percent (n=1,051) had obstructive airway disease based on at least one of the following: FEV1/FVC, bronchodilator responsiveness, hyperactivity or elevated residual volume. After adjusting for age, gender, race, height and weight, and tobacco use, lung function decline was still correlated with airway obstruction. Chest CT scans also revealed that few participants had interstitial lung disease. This article is published in the March issue of CHEST, the peer-reviewed journal of the American College of Chest Physicians: CHEST 2010; 137(3):566�.

PSYCHOLOGICAL DISTRESS PREVALENT AMONG PATIENTS WITH ASTHMA

Psychological disorders, such as anxiety and depression, are twice as prevalent among adults with asthma than the general population. Researchers from the Air Pollution and Respiratory Branch of the Centers for Disease Control analyzed data from 186,738 adult respondents from the 2001-2007 National Health Interview Survey. Results showed that the average annual prevalence of current asthma was 7.0 percent. Among adults with asthma, the prevalence of serious psychological distress (SPD) was 7.5 percent, compared with 3.0 percent among the general population. Furthermore, adults who reported lower socioeconomic status, history of smoking or alcohol abuse, and more comorbid chronic conditions had significantly higher odds of SPD. The findings suggest the importance of mental health screenings for adults with asthma. The article is published in the March issue of CHEST, the peer-reviewed journal of the American College of Chest Physicians: CHEST 2010; 137(3):609�.


'/>"/>

Contact: Jennifer Stawarz
jstawarz@chestnet.org
847-498-8306
American College of Chest Physicians
Source:Eurekalert

Related medicine news :

1. News briefs from the February issue of Chest
2. News briefs from the January issue of Chest
3. Plastic Surgery 2009 news briefs
4. Plastic Surgery 2009 News Briefs - Selected Research to be Presented on Tuesday, October 27
5. Plastic Surgery 2009 News Briefs - Selected Research to be Presented on Monday, October 26
6. Plastic Surgery 2009 News Briefs - Select Research to be Presented on Sunday, October 25
7. Plastic Surgery 2009 News Briefs -- Research To Be Presented on Saturday, October 24
8. News briefs from the October issue of Chest
9. News briefs from the August issue of Chest
10. Highlights of Economic and Business Growth in the Tampa Bay Region (News Briefs)
11. News briefs from the July issue of CHEST
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/22/2017)... ... 22, 2017 , ... “To Walk Away”: a captivating and romantic sequel ... Koontz. “To Walk Away” is the creation of published author, Larry R. Sherman, a ... manuscripts in chemistry and religion, as well as four novels. , Though the ...
(Date:8/22/2017)... ... August 22, 2017 , ... “Covert Awakening”: Walid’s spiritual ... published author, Julianne Hale, a consultant for the Intelligence Community. For more ... on the Near East region. Julianne has written hundreds of reports for ...
(Date:8/22/2017)... (PRWEB) , ... August 22, 2017 , ... TopConsumerReviews.com recently ... to fight Fatigue . , As the stress of modern life continually makes ... the pace. Constant use of artificial stimulants can trap people in vicious high/low cycles ...
(Date:8/21/2017)... ... , ... PracticeMatch, a company that provides online resources , job ... practitioners like nurse practitioners and physician assistants , will conduct its ... year. The online career fairs will allow job seekers to connect with healthcare employers ...
(Date:8/21/2017)... ... August 21, 2017 , ... Los ... plastic surgery fellows for academic year 2017-2018, Christina M. Busuito, M.D. and Lukasz ... completed residency in Plastic and Reconstructive Surgery. The candidate will have the ...
Breaking Medicine News(10 mins):
(Date:7/26/2017)... E.I. Medical Imaging (EIMI) has partnered with ... design the worlds first ultrasound system to be used underwater ... habitat. In preparation for a piece produced by Icon ... Dr. Guttridge approached EIMI with the idea of an underwater ... sharks underwater. EIMI ...
(Date:7/26/2017)... , July 26, 2017 Sancilio Pharmaceuticals ... of our clinical trial evaluating Altemia TM , an ... (SCA) and Sickle Cell Disease (SCD). The SCOT Trial, ... the efficacy and safety of Altemia TM in ... conducted under US IND 125274. ...
(Date:7/25/2017)... CAMBRIDGE, Massachusetts , July 25, 2017 The ... treat rare nervous system diseases, has concluded a worldwide license ... the drug SOM0226 against transthyretin amyloidosis (ATTR). Before this licensing ... in a Phase 2 study conducted in Europe ... the United States ...
Breaking Medicine Technology: